Given the final results of GOG258, what regimen do you recommend use to treat Stage III endometrial cancer?  

Since there is no overall survival benefit, does the local control benefit outweigh the increased risk for distant metastasis? How do you select patients who are appropriate for chemoRT? Does vaginal brachytherapy alone also have a role? What about the sequencing of chemo vs RT?



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Southcoast Centers for Cancer Care
Based on the recent results at SGO 2023 (No Surviv...
Radiation Oncologist at Vanderbilt-Ingram Cancer Center
I have changed institutions since my original post...
at Renown Regional Medical Center
Yes.
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Community Practice